Epithelial Na channel (ENaC) polymorphisms in hyptertention

高血压中的上皮钠通道 (ENaC) 多态性

基本信息

项目摘要

DESCRIPTION (provided by applicant): Blood pressure is controlled, in part, by regulated sodium reabsorption at the distal renal nephron. Here, activity of the epithelial Na channel (ENaC) is limiting for sodium reabsorption. Aldosterone, the final hormone in the renin-angiotensin-aldosterone-system (RAAS), increases ENaC activity to increase blood pressure. Humans control blood pressure through a classic negative-feedback mechanism with RAAS activating ENaC as blood pressure falls. All forms of inheritable, monogenic hypertension are associated with salt-sensitivity and result from inappropriate activation of ENaC in the face of elevated blood pressure. These severe but rare hypertensive diseases result from either gain of function mutations in ENaC or its upstream regulator RAAS. The more prevalent but less severe essential hypertension is a manifestation of a polygenic predisposition towards elevated blood pressure exacerbated by life-style choices and environmental factors. Much essential hypertension particularly that in African American populations is associated with salt-sensitivity and low renin and aldosterone levels. Due to negative-feedback regulation, hypertension with salt-sensitivity, low renin and aldosterone implicates ENaC dysfunction. Molecular genetic studies identified sequence variations (polymorphisms) in ENaC enriched in African American populations. Possible linkage between four ENaC polymorphisms prevalent in African American populations, (alphaT334A, C618F, T663A and beta T594M) with low-renin/aldosterone hypertension has recently been suggested; however, the effects of these polymorphisms on ENaC function remain to be tested. Thus, it is unclear if these polymorphisms can play a causative role in some forms of salt-sensitive hypertension. The current proposal addresses this question by testing the hypothesis that ENaC polymorphisms increase channel activity. Our laboratory is well positioned to conduct this investigation for we are capable of assessing function of recombinant ENaC in a mammalian expression system. We will utilize this expertise to address two Specific Aims: 1) Determine the effects of ENaC polymorphisms on channel activity; and 2) Determine the cellular/molecular mechanisms by which polymorphic ENaC has increased activity. Preliminary results support the feasibility of this investigation and suggest that this line of inquiry will yield significant and novel findings.
描述(由申请人提供):血压的控制部分是通过调节肾远端肾单位的钠重吸收。在这里,上皮性钠通道(ENaC)的活性对钠的重吸收是有限的。醛固酮是肾素-血管紧张素-醛固酮系统(RAAS)中的最后一种激素,它能增加ENaC的活性,从而提高血压。人类通过一种经典的负反馈机制控制血压,当血压下降时,RAAS激活ENaC。所有形式的遗传性单基因高血压都与盐敏感有关,是在血压升高时ENaC不适当激活的结果。这些严重但罕见的高血压疾病要么是ENaC功能突变的获得,要么是它的上游调节因子RAAS的结果。更普遍但不那么严重的原发性高血压是多基因倾向于高血压的表现,生活方式的选择和环境因素加剧了这种倾向。许多原发性高血压,特别是在非裔美国人中,与盐敏感和低肾素和醛固酮水平有关。由于负反馈调节,盐敏感、低肾素和低醛固酮的高血压与ENaC功能障碍有关。分子遗传学研究发现,ENaC的序列变异(多态)在非裔美国人群体中丰富。最近发现在非裔美国人中流行的四种ENaC基因(α-T334A、C618F、T663A和β-T594M)可能与低肾素/醛固酮高血压有关;然而,这些多态对ENaC功能的影响仍有待测试。因此,目前尚不清楚这些基因多态是否在某些形式的盐敏感型高血压中起到致病作用。目前的提案通过检验ENaC基因多态增加通道活性的假设来解决这个问题。我们的实验室有能力进行这项研究,因为我们能够评估重组ENaC在哺乳动物表达系统中的功能。我们将利用这一专业知识来解决两个具体目标:1)确定ENaC多态对通道活性的影响;2)确定多态ENaC增加活性的细胞/分子机制。初步结果支持这项调查的可行性,并表明这一调查路线将产生重大和新颖的发现。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James D Stockand其他文献

James D Stockand的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James D Stockand', 18)}}的其他基金

Purinergic regulation of ENaC in the distal nephron
远端肾单位 ENaC 的嘌呤能调节
  • 批准号:
    10132733
  • 财政年份:
    2018
  • 资助金额:
    $ 14.6万
  • 项目类别:
Purinergic regulation of ENaC in the distal nephron
远端肾单位 ENaC 的嘌呤能调节
  • 批准号:
    9899746
  • 财政年份:
    2018
  • 资助金额:
    $ 14.6万
  • 项目类别:
Regulation of ENaC by Casein Kinase 2
酪蛋白激酶 2 对 ENaC 的调节
  • 批准号:
    10241447
  • 财政年份:
    2018
  • 资助金额:
    $ 14.6万
  • 项目类别:
Regulation of renal Na handling in the collecting duct by local purinergic tone
局部嘌呤能调节肾集合管中钠的处理
  • 批准号:
    8460882
  • 财政年份:
    2010
  • 资助金额:
    $ 14.6万
  • 项目类别:
Regulation of renal Na handling in the collecting duct by local purinergic tone
局部嘌呤能调节肾集合管中钠的处理
  • 批准号:
    7932682
  • 财政年份:
    2010
  • 资助金额:
    $ 14.6万
  • 项目类别:
Regulation of renal Na handling in the collecting duct by local purinergic tone
局部嘌呤能调节肾集合管中钠的处理
  • 批准号:
    8077236
  • 财政年份:
    2010
  • 资助金额:
    $ 14.6万
  • 项目类别:
Regulation of renal Na handling in the collecting duct by local purinergic tone
局部嘌呤能调节肾集合管中钠的处理
  • 批准号:
    8277403
  • 财政年份:
    2010
  • 资助金额:
    $ 14.6万
  • 项目类别:
Stoichiometry and modular retrieval of ENaC
ENaC 的化学计量和模块化检索
  • 批准号:
    7088155
  • 财政年份:
    2006
  • 资助金额:
    $ 14.6万
  • 项目类别:
Stoichiometry and modular retrieval of ENaC
ENaC 的化学计量和模块化检索
  • 批准号:
    7390345
  • 财政年份:
    2006
  • 资助金额:
    $ 14.6万
  • 项目类别:
Epithelial Na channel (ENaC) polymorphisms in hyptertention
高血压中的上皮钠通道 (ENaC) 多态性
  • 批准号:
    7229813
  • 财政年份:
    2006
  • 资助金额:
    $ 14.6万
  • 项目类别:

相似海外基金

Manipulation and engineering of lipid metabolic pathways in CHO cells to enhance processability of cell culture supernantants
CHO 细胞中脂质代谢途径的操作和工程,以增强细胞培养上清液的可加工性
  • 批准号:
    2873335
  • 财政年份:
    2023
  • 资助金额:
    $ 14.6万
  • 项目类别:
    Studentship
Glycoengineering of CHO cells to express recombinant alpha-1 antitrypsin
CHO细胞的糖工程表达重组α-1抗胰蛋白酶
  • 批准号:
    10484110
  • 财政年份:
    2022
  • 资助金额:
    $ 14.6万
  • 项目类别:
Evaluation of antibody-heterogeneity in CHO cells
CHO 细胞中抗体异质性的评估
  • 批准号:
    20K15105
  • 财政年份:
    2020
  • 资助金额:
    $ 14.6万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidating the signalling pathways important for antibody production and secretion in CHO cells
阐明 CHO 细胞中抗体产生和分泌的重要信号通路
  • 批准号:
    2467836
  • 财政年份:
    2020
  • 资助金额:
    $ 14.6万
  • 项目类别:
    Studentship
Combinatorial approaches to engineer CHO cells to enhance production of difficult-to-express therapeutic proteins
改造 CHO 细胞的组合方法以增强难以表达的治疗性蛋白质的产生
  • 批准号:
    BB/T508615/1
  • 财政年份:
    2019
  • 资助金额:
    $ 14.6万
  • 项目类别:
    Training Grant
Development of rapid production of antibody drugs using a single-copy gene expression system in CHO cells
开发利用 CHO 细胞单拷贝基因表达系统快速生产抗体药物
  • 批准号:
    19K05178
  • 财政年份:
    2019
  • 资助金额:
    $ 14.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Utilization of chromosomal instability in CHO cells in recombinant protein production
在重组蛋白生产中利用 CHO 细胞染色体不稳定性
  • 批准号:
    19K21105
  • 财政年份:
    2018
  • 资助金额:
    $ 14.6万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Development of a novel inducible expression system for the manufacture of therapeutic proteins from CHO cells.
开发一种新型诱导表达系统,用于从 CHO 细胞生产治疗性蛋白质。
  • 批准号:
    104199
  • 财政年份:
    2018
  • 资助金额:
    $ 14.6万
  • 项目类别:
    Collaborative R&D
Developing novel biosensors for monitoring antibody production in CHO cells.
开发新型生物传感器来监测 CHO 细胞中抗体的产生。
  • 批准号:
    1983469
  • 财政年份:
    2018
  • 资助金额:
    $ 14.6万
  • 项目类别:
    Studentship
Cell and Process Engineering for Transient Expression of Recombinant Proteins in CHO Cells
CHO 细胞中重组蛋白瞬时表达的细胞和工艺工程
  • 批准号:
    2122943
  • 财政年份:
    2018
  • 资助金额:
    $ 14.6万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了